Zetia Cost in Missouri 2026: Cash Price, Medicaid, Insurance, and Savings Options

What Is Ezetimibe and Why Does the Price Vary So Much?

Ezetimibe is a cholesterol-absorption inhibitor that blocks the Niemann-Pick C1-like 1 (NPC1L1) transporter in the small intestine, reducing LDL cholesterol by 18 to 20 percent as monotherapy and by an additional 23 to 24 percent when added to a statin [1]. The FDA approved the brand Zetia in 2002, and Merck held exclusivity until 2017, when multiple generic manufacturers entered the market. That patent expiration is the single biggest reason Missouri patients now see a $365 gap between the brand list price and the generic cash price.

The list price for brand Zetia sits near $380 per month in 2026 [2]. That number reflects what a pharmacy bills before any insurance, coupon, or manufacturer discount. Generic ezetimibe 10 mg tablets at Missouri pharmacies average about $15 per month when purchased with a discount card such as GoodRx or through a large-chain pharmacy's generic drug program [3]. No patient in Missouri should be paying list price for ezetimibe in 2026.

Ezetimibe's clinical significance was established firmly by the IMPROVE-IT trial published in the New England Journal of Medicine in 2015. IMPROVE-IT (N=18,144) showed that adding ezetimibe 10 mg to simvastatin 40 mg reduced the composite of cardiovascular death, major coronary events, or stroke by 6.4 percent relative to simvastatin alone over a median follow-up of six years, with a number-needed-to-treat of 50 [4]. That cardiovascular outcome benefit is why prescribers and guideline panels take ezetimibe seriously as a second-line agent when statins alone fail to meet LDL targets.

The 2022 ACC/AHA Guideline on Cardiovascular Risk Reduction states: "In patients with clinical ASCVD and LDL-C remaining above goal on maximally tolerated statin therapy, adding ezetimibe is a reasonable next step before initiating PCSK9 inhibitor therapy" [5]. That guidance makes ezetimibe relevant for a substantial portion of Missouri's adult population given that Missouri's age-adjusted cardiovascular disease mortality rate exceeds the national average.

Generic Ezetimibe vs. Brand Zetia: Which Should Missouri Patients Request?

Generic ezetimibe is therapeutically identical to brand Zetia. The FDA requires all generic equivalents to demonstrate bioequivalence within a 90 percent confidence interval of 80 to 125 percent for AUC and C-max [6]. Multiple manufacturers, including Sandoz, Teva, and Aurobindo, produce 10 mg ezetimibe tablets. The active ingredient, dose, route, and indication are the same.

Generic is cheaper. Full stop.

At Missouri Walmart pharmacies, the $4 generic program covers ezetimibe 10 mg in many locations. Costco and Sam's Club pharmacies in the St. Louis and Kansas City metro areas frequently list ezetimibe under $10 for a 30-day supply. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists ezetimibe 10 mg at approximately $6 for 30 tablets, and Missouri residents can use that service by mail. Prices fluctuate quarterly, so confirming the current figure at your specific pharmacy before filling is the right move.

The following decision framework captures how Missouri patients should choose among formulation types in 2026:

1. Ask for generic ezetimibe first. If your prescriber writes "Zetia," ask the pharmacist to substitute the generic unless you have a specific reason (such as a documented excipient sensitivity) to use the brand.
2. Apply a discount card regardless of your insurance status. GoodRx, RxSaver, and NeedyMeds all negotiate below the standard cash price at Missouri-licensed retail pharmacies.
3. Check the Merck Savings Card eligibility before dismissing brand Zetia entirely. Eligible commercially insured patients may pay as little as $5 per 30-day supply through the Merck savings program [7].
4. Consider a 90-day supply. Most Missouri chain pharmacies offer a lower per-tablet price on 90-day fills, and Missouri's Medicaid preferred drug list allows 90-day supplies for covered medications.

Missouri Medicaid Coverage for Ezetimibe: What MO HealthNet Actually Pays

Missouri Medicaid, administered as MO HealthNet, does cover ezetimibe, but with a significant restriction. As of 2026, MO HealthNet covers ezetimibe only when the patient carries a diagnosis of type 2 diabetes mellitus. Patients seeking ezetimibe solely for primary hypercholesterolemia or mixed hyperlipidemia without a concurrent T2D diagnosis will find ezetimibe listed as non-covered on the standard formulary tier [8].

That restriction affects a substantial number of Missouri residents. According to the CDC, 11.6 percent of Missouri adults have diagnosed diabetes, a figure above the national median of 11.3 percent [9]. Patients who do qualify under the T2D criterion receive generic ezetimibe at the standard MO HealthNet cost-sharing level, which is $3.90 per prescription for most adults in 2026.

If you do not have T2D but need ezetimibe through MO HealthNet, your prescriber can submit a prior authorization (PA) request documenting medical necessity. PA approval is possible when a patient has confirmed ASCVD, a documented intolerance to multiple statins at maximum dose, and an LDL level above the guideline threshold despite best available therapy. The PA process typically requires a 15-business-day review cycle under MO HealthNet policy, though expedited reviews are available for urgent cases within 72 hours.

MO HealthNet managed care plans, including Centene (Missouri Care) and Anthem HealthKeepers Plus, may have slightly different formulary tiers than the fee-for-service program. Beneficiaries enrolled in a managed care plan should call the plan's pharmacy services line to confirm the ezetimibe prior authorization criteria specific to that plan.

Compounded Ezetimibe in Missouri: Legal Status and Practical Reality

Compounded ezetimibe is legally available in Missouri through 503A compounding pharmacies. Section 503A of the federal Food, Drug, and Cosmetic Act governs patient-specific compounding and permits licensed state pharmacies to compound ezetimibe when a licensed prescriber writes a valid prescription for an identified individual patient [10]. Missouri does not have state-level prohibitions that go beyond the federal 503A framework for this drug.

Why would someone choose compounded over commercially manufactured generic ezetimibe? The most common reason is combination with other compounded agents, such as ezetimibe combined with a specific statin strength that is not commercially available or with berberine in a single capsule to reduce pill burden. Some telehealth providers also supply compounded ezetimibe as part of a broader cardiovascular metabolic protocol, with costs negotiated into a membership fee. In those arrangements the out-of-pocket price to the patient can effectively be $0 per month depending on the program structure.

The FDA has not placed ezetimibe on any list of drug products that may not be compounded under 503A. The agency's guidance on compounding distinguishes between drugs on the "difficult to compound" list and standard small-molecule drugs for which compounding is routine. Ezetimibe, as an oral small-molecule tablet, falls in the routine category [11].

Practical caution applies. Compounded preparations are not FDA-approved finished drug products. Quality, potency, and sterility testing standards differ between compounding pharmacies. Missouri patients using a 503A compounding pharmacy should verify that the pharmacy holds a current Missouri Board of Pharmacy (MOBOP) license and participates in routine third-party potency testing. Asking the pharmacy directly for a certificate of analysis on any batch is a reasonable request. The Missouri Board of Pharmacy maintains a license verification search at pr.mo.gov.

Zetia Insurance Coverage in Missouri: Tiers, PAs, and What to Expect From Commercial Plans

Across Missouri commercial insurance plans in 2026, ezetimibe occupies one of two positions: generic tier (Tier 1 or Tier 2) or non-preferred brand tier (Tier 3) depending on whether the plan has adopted the generic on its formulary.

The largest commercial payers in Missouri, including Anthem Blue Cross Blue Shield of Missouri, Cigna, Aetna, and UnitedHealthcare of the Midwest, all cover generic ezetimibe on Tier 1 or Tier 2. At Tier 1, typical Missouri employer plan cost-sharing runs $10 to $20 per 30-day fill. At Tier 2, the range is $30 to $50. Brand Zetia, if sought on a plan that carries it at Tier 3 or non-formulary, may require a PA and could cost $80 to $120 after insurance, which is why defaulting to generic remains the financially rational choice for most patients.

Medicare Part D plans in Missouri must cover ezetimibe under the hypolipidemic drug category. Coverage tier varies by plan. Missouri residents in the Low Income Subsidy (Extra Help) program pay no more than $4.50 per generic fill in 2026 under the standard Extra Help copay schedule.

The Missouri Department of Insurance regulates commercial insurer formulary practices and requires coverage decisions to be accessible to enrollees. If an insurer denies ezetimibe coverage, Missouri's external review law (RSMo 376.1376) entitles the enrollee to an independent external review when the denial is based on medical necessity grounds.

The Merck Savings Card and Other Discount Programs Available in Missouri

Merck operates a Zetia Savings Card program directly available to commercially insured Missouri patients. Under the 2026 program terms, eligible patients pay as little as $5 per 30-day prescription of brand Zetia [7]. Eligibility requires a valid commercial insurance card; patients with Medicare, Medicaid, or other federal program coverage are excluded from the savings card by law.

GoodRx consistently shows Missouri prices for generic ezetimibe in the $12 to $18 range at CVS, Walgreens, Hy-Vee, and Schnucks pharmacy locations, depending on the city. The GoodRx Gold membership, priced at $9.99 per month for an individual or $19.99 for a family, may reduce ezetimibe further to approximately $6 to $10 at participating Missouri pharmacies, though the breakeven math only favors Gold membership if you fill multiple prescriptions monthly.

NeedyMeds.org maintains a database of patient assistance programs (PAPs). Merck's Patient Assistance Program covers brand Zetia at no cost for uninsured or underinsured Missouri patients who meet income thresholds (generally at or below 400 percent of the federal poverty level) [12]. The application requires a prescriber signature and proof of income. Processing takes approximately 4 to 6 weeks for initial enrollment, so planning ahead is necessary.

RxOutreach, a Missouri-based nonprofit mail-order pharmacy headquartered in St. Louis, offers ezetimibe 10 mg at reduced cost to qualifying patients. Income eligibility is set at or below 300 percent of the federal poverty level. A 90-day supply through RxOutreach typically costs $20 to $30 for eligible patients, making it one of the lowest-cost legitimate options for uninsured Missourians who do not qualify for MO HealthNet.

Telehealth Prescribing of Ezetimibe in Missouri: Getting a Prescription Without an In-Person Visit

Missouri law permits telehealth prescribing of ezetimibe with no in-person visit requirement for most patients. Under Missouri's telehealth statute (RSMo 191.1145), a prescriber who establishes a valid prescriber-patient relationship via a synchronous audio-video encounter can issue a prescription for non-controlled substances including ezetimibe [13]. Ezetimibe is not a controlled substance, so no DEA registration or special waiver is needed.

Telehealth workflows for ezetimibe typically involve a brief cardiovascular risk intake, a review of recent lipid panel results (most prescribers want values from within the past 12 months), and a medication history to confirm that statin therapy has been considered or tried. The entire process from signing up to receiving a prescription can take under 30 minutes with a well-designed telehealth platform.

Missouri patients should ensure that the telehealth provider's prescriber holds an active Missouri medical license. License verification is available through the Missouri Division of Professional Registration (pr.mo.gov). Out-of-state providers using a compact license (Missouri participates in the Interstate Medical Licensure Compact) may also prescribe legally.

Lab requirements vary by platform. Some telehealth providers will prescribe ezetimibe based on a patient-reported or uploaded lipid panel. Others require a lab order drawn through a Missouri LabCorp or Quest Diagnostics location. If you are starting ezetimibe through telehealth, anticipate that your prescriber will want a follow-up lipid panel 4 to 12 weeks after initiation to confirm therapeutic response, consistent with American College of Cardiology guidance on LDL monitoring [5].

Clinical Considerations: Who Actually Benefits From Ezetimibe in Missouri's Patient Population?

Ezetimibe is most useful in three specific patient groups. First, patients with heterozygous familial hypercholesterolemia (HeFH) who cannot reach LDL targets on maximally tolerated statin doses. Second, patients with confirmed clinical ASCVD, including those post-MI or post-ACS, where the IMPROVE-IT data directly applies. Third, patients who are statin-intolerant due to myopathy or hepatotoxicity and need an alternative LDL-lowering agent.

For patients in the first two categories, the 2022 ACC/AHA guidelines specify an LDL threshold of <70 mg/dL for very-high-risk ASCVD patients and <55 mg/dL for those with multiple major ASCVD events [5]. Ezetimibe alone typically lowers LDL by 15 to 20 percent, which may close the gap to target without requiring a PCSK9 inhibitor, which costs $500 to $700 per month even with rebates.

Ezetimibe is generally well-tolerated. The most commonly reported adverse events in IMPROVE-IT (N=18,144) were diarrhea (4.1 percent for the ezetimibe group vs. 3.7 percent placebo group) and myalgia at rates not statistically different from placebo [4]. No significant hepatotoxicity signal was observed in the trial's six-year follow-up. For patients already concerned about statin-associated muscle symptoms, ezetimibe's clean safety profile is a practical advantage.

Pregnant patients should note that ezetimibe is FDA Category X. The FDA prescribing information states that ezetimibe is contraindicated in pregnancy, as cholesterol is required for normal fetal development, and that patients should be counseled to stop ezetimibe immediately if pregnancy occurs [2]. Missouri prescribers using telehealth must screen for pregnancy status before initiating ezetimibe in women of childbearing potential.

Practical Steps for Missouri Patients Starting Ezetimibe in 2026

Getting ezetimibe at the lowest possible cost in Missouri comes down to a predictable sequence. Your prescriber writes for generic ezetimibe 10 mg once daily. You take that prescription to a pharmacy or mail-order service, enter a GoodRx code (or use Cost Plus Drugs by mail), and expect to pay roughly $15 or less for a 30-day supply. If you have commercial insurance, the generic tier copay may be even lower. If you have MO HealthNet with a T2D diagnosis, you pay $3.90.

The only scenario where you should spend more than $20 per month on ezetimibe in Missouri is if a specific combination product or compounded formulation serves a clinical purpose your prescriber has documented. Brand Zetia at list price is never necessary when the FDA-equivalent generic is available at every Missouri pharmacy for one-twentieth the cost.

Ask your prescriber for a 90-day supply at initiation. Missouri law allows pharmacists to dispense a 90-day supply of chronic medications without a new prescription when the original was written for 30-day fills with refills. A 90-day generic fill at Cost Plus Drugs runs approximately $18 for 90 tablets, roughly $0.20 per dose.